U.S. Stomach Cancer Treatment Market Size & Outlook
U.S. stomach cancer treatment market, 2018-2028 (US$M)
Related Markets
U.S. stomach cancer treatment market highlights
- The U.S. stomach cancer treatment market generated a revenue of USD 689.2 million in 2020 and is expected to reach USD 2,005.8 million by 2028.
- The U.S. market is expected to grow at a CAGR of 14.3% from 2021 to 2028.
- In terms of segment, targeted therapy was the largest revenue generating treatment type in 2020.
- Immunotherapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.
Stomach cancer treatment market data book summary
| Market revenue in 2020 | USD 689.2 million |
| Market revenue in 2028 | USD 2,005.8 million |
| Growth rate | 14.3% (CAGR from 2020 to 2028) |
| Largest segment | Targeted therapy |
| Fastest growing segment | Immunotherapy |
| Historical data | 2018 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Standard Chemotherapy, Targeted Therapy, Immunotherapy |
| Key market players worldwide | Novartis AG ADR, Pfizer Inc, Viatris Inc, Roche Holding AG ADR, Eli Lilly and Co, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Co, Celltrion Healthcare, Samsung Bioepis |
Other key industry trends
- In terms of revenue, U.S. accounted for 19.7% of the global stomach cancer treatment market in 2020.
- Country-wise, Japan is expected to lead the global market in terms of revenue in 2028.
- In North America, U.S. stomach cancer treatment market is projected to lead the regional market in terms of revenue in 2028.
- Canada is the fastest growing regional market in North America and is projected to reach USD 72.9 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Stomach Cancer Treatment Market Scope
Stomach Cancer Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. stomach cancer treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stomach cancer treatment market will help companies and investors design strategic landscapes.
Targeted therapy was the largest segment with a revenue share of 54.35% in 2020. Horizon Databook has segmented the U.S. stomach cancer treatment market based on standard chemotherapy, targeted therapy, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2028.
Reasons to subscribe to U.S. stomach cancer treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. stomach cancer treatment market databook
-
Our clientele includes a mix of stomach cancer treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. stomach cancer treatment market , including forecasts for subscribers. This country databook contains high-level insights into U.S. stomach cancer treatment market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. stomach cancer treatment market size, by treatment type, 2018-2028 (US$M)
U.S. Stomach Cancer Treatment Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
